Rapamune 1 mg / ml Oral solution

Licence status
Authorised: 13/03/2001
Active substances
Sirolimus
Dosage Form
Oral solution
Licence number
EU/1/01/171/001
Licence holder
Pfizer Europe MA EEIG

Product documents

Licence information

ATC code
L04AA Selective immunosuppressants, L04AA10 sirolimus
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
13/03/2001